Premier Biomedical Developing Revolutionary Medical Cures

JACKSON CENTER, Pa.--(BUSINESS WIRE)--Premier Biomedical, Inc. (OTCBB: BIEI) announced that they have begun trading on the OTC-BB fully reporting index at “BIEI”. Premier Biomedical Inc’s principal technology is based on the Felder Doctrine™, “To physically remove the pathophysiologic basis of the disease.” This revolutionary approach to medicine constitutes a micro-surgical eradication of the cause of a multitude of diseases and is designed to find cures for 19 of the most severe diseases, including Cancer, Alzheimer’s Disease, Leukemia, Heart Attacks, Strokes, ALS, and AIDS.

Back to news